Clinical trials
Placebo - Control clinical trials
Below are recruiting placebo - control clinical trials, each written for real people, not researchers. We’re tracking 3,955 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07085507RecruitingPhase 1/Phase 2
Testing a new drug for multiple sclerosis in healthy people and MS patients
This trial tests an experimental oral drug called VT7208 in both healthy volunteers and people with multiple sclerosis (MS). The goal is to see if it is safe and how the body processes it, which could lead to a new treatment option for MS.
Adelaide, South AustraliaAges 18–65 - NCT07086521RecruitingPhase 1
Stem cell therapy for facioscapulohumeral muscular dystrophy
This trial tests a new stem cell treatment (ULSC) for people with FSHD, a type of muscular dystrophy. It aims to see if the treatment is safe and if it can help improve arm strength and daily movement.
Palo Alto, CaliforniaAges 15 years+ - NCT07086976RecruitingPhase 3
Study of oral rilzabrutinib for warm autoimmune hemolytic anemia
This trial tests an oral medication (rilzabrutinib) against a placebo for people with warm autoimmune hemolytic anemia (wAIHA). It aims to see if the drug can help control the disease with fewer side effects than current treatments.
Phoenix, ArizonaAges 18 years+ - NCT07087262RecruitingPhase 1
Study of a new medicine called SNH-119014 in healthy volunteers
This trial tests a new drug called SNH-119014 for the first time in humans. It involves healthy volunteers to check the drug's safety and how the body processes it. It may be a step toward a new treatment for certain conditions.
Hefei, AnhuiAges 18–45 - NCT07088302Recruiting
Lactase enzyme for feeding intolerance in preterm babies
This trial tests if giving lactase enzyme supplements helps preterm babies (born at or before 32 weeks) tolerate their feedings better. If your baby was born early and started feeding within the first few days of life, this study may be a good fit.
AlexandriaAges 3 days–1 month - NCT07088380RecruitingPhase 3
Ketamine combined with ECT for hard-to-treat depression
This trial tests whether adding ketamine to electroconvulsive therapy (ECT) works better than ECT alone for people with depression that hasn't improved with at least two different antidepressants. It may offer a new option for those who have not found relief from standard treatments.
MilanAges 18–70 - NCT07089238Recruiting
Citicoline for mood in healthy adults
This study tests whether a supplement called citicoline can improve mood in healthy adults who have some mild mood disturbance. It is designed to see if taking citicoline leads to a better mood.
Canfield, OhioAges 21–65 - NCT07090161RecruitingPhase 2
Study of iloperidone for uncontrolled high blood pressure
This trial tests if iloperidone can lower blood pressure in people whose high blood pressure is not controlled by current medications. You may qualify if your blood pressure is still high after weeks of treatment.
Phoenix, ArizonaAges 18–65 - NCT07090759RecruitingPhase 3
Test of new drug for hepatitis B not fully controlled by current treatment
This trial tests a new drug called GST-HG141 for people with chronic hepatitis B whose virus is still active despite taking standard antiviral pills. It aims to see if the new drug can better control the virus.
Hangzhou, ZhejiangAges 18–70 - NCT07090785RecruitingPhase 1
Healthy volunteer study of LY4088044
This trial tests a new medicine called LY4088044 in healthy people to see how it affects the body. It helps doctors learn about the drug's safety before testing it in patients with a disease.
Los Alamitos, CaliforniaAges 18–65 - NCT07090928RecruitingPhase 4
Numbing medicine for less pain after knee scope surgery
This study tests whether giving bupivacaine (a numbing medicine) around the time of knee arthroscopy can reduce pain at the surgery sites and help you move your knee better after the operation.
Peshawar, KPKAges 18–70 - NCT07091279RecruitingPhase 2
Test of Propranolol for Severe Behaviors in Autism
This study tests a medication called propranolol to see if it can reduce aggression and other severe behaviors in adolescents and adults with autism. It might be an option if you have frequent and serious challenging behaviors that other treatments haven't helped.
Staten Island, New YorkAges 12–40 - NCT07092709RecruitingPhase 3
Tenecteplase for stroke patients who recently took blood thinners
This trial tests if the clot-busting drug tenecteplase is safe and effective for people having an ischemic stroke who have recently taken blood thinners (DOACs). If you qualify, you may receive either tenecteplase or a placebo within 24 hours of your last known well time.
Guangzhou, GuangdongAges 18 years+ - NCT07093060RecruitingEarly Phase 1
Oxytocin and atosiban effects on social attention
This trial tests how two oral medications, oxytocin and atosiban, affect the way healthy men pay attention to social cues. It aims to understand how these drugs influence social brain function.
Chengdu, SichuanAges 18–35 - NCT07093580RecruitingPhase 1
Study of a long-acting injectable in healthy adults
This study tests a new long-acting injectable medication (S-892216 LAI) in healthy adults. It helps researchers understand how the drug works in the body when given as a shot, which could lead to a treatment given less often in the future.
Lenexa, KansasAges 18–55 - NCT07094035Recruiting
Green tea and probiotics for constipation-predominant IBS
This study tests whether a supplement containing green tea extract and probiotics can improve bowel function in people with irritable bowel syndrome (IBS) that mainly causes constipation. If you have chronic constipation and abdominal pain, this could help.
NaplesAges 18–70 - NCT07096908RecruitingPhase 4
Tirzepatide for weight loss in type 1 diabetes
This study tests a medication called tirzepatide for people with type 1 diabetes who also have overweight or obesity. Tirzepatide may help with weight loss and blood sugar control, and you'll use a continuous glucose monitor throughout the study.
Kuwait City, SharqAges 21 years+ - NCT07097012RecruitingPhase 4
Whooping cough and RSV vaccines: together or separate in pregnancy
This study tests whether giving two vaccines—one for whooping cough (Tdap) and one for RSV—at the same time is safe and effective compared to giving them separately during pregnancy. It may help protect your baby from both diseases early in life.
Vancouver, British ColumbiaAges 18–49 - NCT07098026Recruiting
Herbal mixture plus chemo before surgery for advanced stomach cancer
This trial tests whether adding an herbal mixture (Shenqi Fuwei Mixture) to standard chemotherapy before surgery can help treat locally advanced stomach cancer. It is for people whose cancer has not spread to distant sites and who are healthy enough to undergo treatment and surgery.
Changsha, HunanAges 18–75 - NCT07098663RecruitingPhase 2
Study of MKP10241 for weight loss and diabetes control
This study tests an investigational drug called MKP10241 in healthy people, people with obesity, and people with type 2 diabetes. It aims to see how the drug affects blood sugar, weight, and overall safety. It may be an option if you have obesity or type 2 diabetes managed by diet and/or metformin.
Bayswater, VictoriaAges 18–60 - NCT07098780RecruitingPhase 4
Tranexamic Acid to Prevent Bleeding in Weight Loss Surgery
This trial tests whether a medicine called tranexamic acid (TXA) can reduce bleeding during weight loss surgery. If you are having a sleeve gastrectomy or mini-gastric bypass, taking TXA may lower your risk of hemorrhagic events.
Karachi, SindhAges 18–60 - NCT07098975RecruitingPhase 2
Statin for severe early-onset placental insufficiency
This trial tests if taking pravastatin (a statin) can improve blood flow to the placenta in pregnant people with either severe early-onset preeclampsia (high blood pressure) or a baby not growing well. The goal is to help the pregnancy last longer and improve outcomes.
BarcelonaAges 18 years+ - NCT07099118RecruitingPhase 1
Safety and tolerability of HEC169584 in healthy people
This early-stage study checks if a new medicine called HEC169584 is safe for people and how it moves through the body. It looks for healthy volunteers to take part.
Beijing, Beijing MunicipalityAges 18–45 - NCT07099859RecruitingPhase 4
Losartan after aortic valve surgery for severe leakage
This trial tests if the drug losartan can help the heart recover better after surgery to replace a leaky aortic valve. It may reduce strain on the heart and improve long-term outcomes.
São Paulo, São PauloAges 18–85
Hear when a new Placebo - Control trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for placebo - control?
- Yes. Clin2 currently lists 3,955 recruiting placebo - control studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a placebo - control trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a placebo - control trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.